Sidharth Mehan Selected Research

propionic acid (potassium propionate)

1/2022	Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism.
1/2022	PI3K/AKT/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult rats.
2/2021	Neuroprotective Effect of α-Mangostin in the Ameliorating Propionic Acid-Induced Experimental Model of Autism in Wistar Rats.
6/2020	Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats.
1/2019	Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sidharth Mehan Research Topics

Disease

9	Mitochondrial Diseases (Mitochondrial Disease) 04/2022 - 02/2017
7	Autistic Disorder (Autism) 06/2022 - 01/2019
5	Demyelinating Diseases (Demyelinating Disease) 06/2022 - 01/2021
5	Cerebral Hemorrhage 01/2022 - 01/2019
5	Nervous System Diseases (Neurological Disorders) 01/2022 - 01/2021
4	Neoplasms (Cancer) 06/2022 - 07/2019
4	Neuroinflammatory Diseases 01/2022 - 01/2019
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 01/2021
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2011
3	Inflammation (Inflammations) 03/2022 - 01/2021
3	Brain Diseases (Brain Disorder) 01/2022 - 01/2021
3	Huntington Disease (Huntington's Disease) 01/2022 - 02/2017
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2017
3	Multiple Sclerosis 01/2021 - 01/2021
2	Dementia (Dementias) 01/2022 - 10/2009
2	Hypertrophy 01/2021 - 01/2018
2	Cognitive Dysfunction 01/2021 - 10/2009
2	Body Weight (Weight, Body) 01/2018 - 02/2017
1	Insulin Resistance 06/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2022
1	Autism Spectrum Disorder 05/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 04/2022
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 03/2022
1	Schizophrenia (Dementia Praecox) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Hematoma 01/2022
1	Disease Progression 01/2022
1	Carcinogenesis 01/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2021
1	Vitiligo 03/2021
1	COVID-19 01/2021
1	Gliosis 01/2021
1	Vertigo (Positional Vertigo) 01/2021
1	Muscle Weakness 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Hemorrhage 06/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Amyloid Plaque 07/2019
1	Tauopathies 07/2019

Drug/Important Bio-Agent (IBA)

8	Neurotransmitter Agents (Neurotransmitter)IBA 04/2022 - 01/2019
8	Neuroprotective AgentsIBA 03/2022 - 02/2017
6	Pharmaceutical PreparationsIBA 05/2022 - 01/2021
6	Adenylyl Cyclases (Adenylyl Cyclase)IBA 03/2021 - 02/2017
5	propionic acid (potassium propionate)IBA 01/2022 - 01/2019
5	CytokinesIBA 01/2022 - 03/2011
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
3	chrysophanic acidIBA 01/2022 - 01/2022
3	solanesolIBA 06/2020 - 11/2018
3	ColforsinIBA 06/2020 - 02/2017
3	Free RadicalsIBA 06/2020 - 01/2018
3	coenzyme Q10 (CoQ10)IBA 06/2020 - 01/2019
3	Streptozocin (Streptozotocin)FDA Link 01/2020 - 10/2009
2	Myelin Basic ProteinIBA 06/2022 - 01/2022
2	Insulin (Novolin)FDA Link 06/2022 - 01/2022
2	4-hydroxyisoleucineIBA 06/2022 - 11/2021
2	PPAR gammaIBA 06/2022 - 01/2022
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 01/2021
2	pregna-4,17-diene-3,16-dione (guggulsterone)IBA 01/2022 - 01/2021
2	mangostinIBA 01/2022 - 02/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 08/2021
2	Ethidium (Ethidium Bromide)IBA 01/2021 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 06/2020 - 02/2017
2	AntioxidantsIBA 06/2020 - 01/2018
2	3-nitropropionic acidIBA 11/2018 - 02/2017
1	Amino Acids FDA Link 06/2022
1	PPAR-gamma AgonistsIBA 06/2022
1	PhytochemicalsIBA 06/2022
1	purmorphamineIBA 03/2022
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 03/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	SynucleinsIBA 01/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 08/2021
1	Melanins (Melanin)IBA 03/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	CotinineIBA 01/2021
1	GliotoxinIBA 01/2021
1	InterferonsIBA 01/2021
1	MercuryIBA 01/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2021
1	NeurotoxinsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	SirtuinsIBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 06/2020
1	desoxyepothilone B (epothilone D)IBA 01/2020
1	BenzodiazepinesIBA 01/2020
1	tau Proteins (tau Protein)IBA 01/2020
1	cabazitaxel FDA Link 01/2020
1	TubulinIBA 07/2019

Therapy/Procedure

4	Therapeutics 01/2022 - 03/2011
1	Injections 01/2022
1	Drug Therapy (Chemotherapy) 01/2021